Hindustan Unilever just delivered its strongest quarterly growth in 14 quarters. The company reported 15% underlying sales growth (USG) and 7% underlying volume growth (UVG) for Q2 FY27, with consolidated turnover of ₹18,071 crore. But here's the thing—the stock barely blinked, and in some accounts, even dipped. Why? Because the story isn't just about growth. It's about what that growth cost, and whether the market believes it can last. Investor Presentation
Let's break down what actually happened, what worked, and what's keeping investors on their toes.
First, let's acknowledge the elephant in the room. 7% volume growth in a challenging macro environment is no small feat. Management describes the underlying demand environment as resilient, supported by healthy macro indicators, and expects FY27 to be better than FY26. But how did they pull it off? Investor Presentation
The answer lies in a deliberate shift away from aggressive price hikes. The company's execution rests on three pillars: calibrated pricing actions, volume-led growth, and accelerated savings. In simpler terms, they stopped passing every bit of cost inflation to consumers. Earlier commentary from the Q1 FY27 call confirms this—management said it had been "very measured" in passing price increases, which were far below inflation. They believe they can sustain margins if crude-linked economics stay in a roughly $75–100 per barrel range. Investor Presentation +3
This approach played out differently across segments. Home Care and Beauty & Wellbeing delivered the goods with double-digit volume growth. Personal Care saw flat volumes, and Foods managed only low-single-digit volume growth. So the 7% headline number isn't uniform—it's being pulled up by the strong performers while others tread water. Investor Presentation +1
Home Care was the star of the show, delivering 22% USG with double-digit volume growth on revenue of ₹6,878 crore. Fabric wash posted strong double-digit growth across liquids, powders, and bars, with all brands contributing. Liquids continued their robust double-digit run, and focused market development expanded penetration. Investor Presentation +3
The Surf Excel Easy Wash ₹99 pack deserves a special mention. The presentation explicitly states that this pack "continued to drive premiumisation in powders and scaled well". But let's be clear about what this means. The ₹99 pack is a driver, not the sole explanation. Growth was broad-based across formats and household care, where Vim Liquids also delivered double-digit, volume-led growth. The pack is part of a larger premiumisation story, not the whole story itself. Investor Presentation +2
Beauty & Wellbeing accelerated to 16% USG, driven by double-digit volume growth. Segment revenue hit ₹4,319 crore with a 29% margin. Hair Care accelerated its double-digit, volume-led growth, while Skin Care and Colour Cosmetics also delivered double-digit, volume-led growth. Premium skin care maintained its trajectory, particularly in organised trade. Investor Presentation +1
The quarter saw several portfolio moves. The company expanded the Simple range with a new Barrier Repair range, relaunched Vaseline body lotion with upgraded packaging, launched premium Body Serum lotions under Dove, and expanded the Minimalist range in skin care and hair care. Management says Minimalist accelerated and strengthened its portfolio in emerging demand spaces. Investor Presentation +1
Here's the causal link, and it's associative rather than proven. These premium innovations are outperforming, and the segment is seeing double-digit volume growth. But some of this strength, like Simple, Vaseline, and Pond's, was already visible in Q1 FY27 before these specific launches. The launches likely contributed to the momentum, but they're building on an existing foundation. The company doesn't disclose brand-level sales or margins, so we can't precisely measure each product's impact. Transcript +1
Personal Care grew 9% in USG, but here's the catch—volume was flat. The growth came mainly from pricing and mix. Within the segment, Skin Cleansing grew double digits, driven by pricing actions. However, focused market development in Pears and Dove bars supported double-digit, volume-led growth within this sub-segment. Bodywash strengthened penetration through more sampling and in-store activations. Oral Care grew at a low-single-digit rate, with premium innovations maintaining their double-digit trajectory. Investor Presentation +2
Foods also delivered 9% USG, but again, volume growth was only in the low single digits. Most of the growth came from pricing and mix. Lifestyle Nutrition accelerated its double-digit growth momentum, with Horlicks Biscuits and ready-to-drink formats growing well. The newly launched Horlicks Protein is seeing "encouraging traction". Beverages saw coffee deliver high-single-digit growth driven by volumes, while tea faced softer performance in mass tea due to inflation, even as premium tea innovations scaled well. Packaged Foods delivered double-digit, broad-based growth, with Kissan condiments relaunched with contemporary packaging and a strengthened proposition. Investor Presentation
The company attributes its performance to its "Winning in New India" strategy, which targets competitive, volume-led profit growth. The presentation frames growth around four pillars: Consumption, Premiumisation, Market Making, and New Spaces. There's also a focus on building a "future-fit Go-to-Market". Investor Presentation +2
But here's where the trade-off becomes visible.
The EBITDA margin was 22.6%, down about 140 basis points year on year, though still within the 22–24% guidance range. Management expects commodity inflation to continue in the short term. Investor Presentation +2
The pattern is consistent with the company prioritising volumes and absorbing part of the cost inflation. The presentation has sections on "Accelerated savings" and "A&P spends productivity," but the retrieved content only shows the headings—no specific figures on gross margin, advertising spend, or savings amounts. The company is investing in market development and premiumisation, and it's paying off in volumes, but it's weighing on margins in the near term. Investor Presentation +1
The company declared an interim dividend of ₹19 per share with its Q2 FY27 results. This is notable because reported profit after tax was flat at ₹2,796 crore, due to a base period that included one-off tax-related gains of ₹273 crore. Profit before exceptional items grew 9% to ₹2,795 crore. Investor Presentation +2
So why pay ₹19 when reported profit is flat? The answer lies in the company's dividend policy, which aims to return excess cash from operations, beyond immediate and foreseeable needs, to shareholders over the long term. It's not tied to a single quarter's profit growth. The interim amount has been stable at ₹19 for two years now. Annual Report +1
But this payout comes at a cost. With about 235 crore shares outstanding, ₹19 per share translates to roughly ₹4,464 crore. Consolidated cash and cash equivalents fell from ₹6,070 crore to ₹2,583 crore in FY26, as dividends and acquisitions exceeded operating cash generation. The company is paying out nearly all earnings while funding premiumisation capex and acquisitions from operating cash flow and its cash balance. The cash cushion is getting thinner. Annual Report +1
Here's where things get interesting.
I couldn't find a source explaining the specific market reaction, so the reasons below are what investors would typically weigh, not what the market actually concluded.
The concern likely centers on the disconnect between 15% USG and reported revenue growth. USG excludes changes from acquisitions and disposals, and I couldn't find a reconciliation between reported and underlying growth for Q2 FY27. If there's a significant gap, investors would question how much of that 15% USG will show up in reported revenue and earnings. Investor Presentation +1
Then there's the margin question. EBITDA grew 8% against 15% USG, and margins compressed. Management expects commodity inflation to continue. The quality of growth is also uneven—Personal Care volumes were flat, and Foods volumes grew only low single digits. The 7% group UVG rests heavily on Home Care and Beauty & Wellbeing. Investor Presentation +2
In essence, the market might be saying: "Great job on volumes, but can you sustain this without sacrificing margins?" The ₹19 dividend signals confidence, but the declining cash balance and margin compression suggest the company is walking a tightrope between investing for growth and rewarding shareholders.
Looking forward, management expects FY27 to be better than FY26, driven by portfolio and channel transformation. The company has a planned capex outlay of about ₹2,000 crore in premium formats. The Capital Markets Day, held on 4 September 2026, may have outlined more details, but those contents weren't available in the retrieved materials. Investor Presentation +3
The story of HUL's Q2 FY27 is one of strategic choices. The company chose volumes over aggressive pricing, premiumisation over margin preservation in the near term, and steady shareholder returns over building a larger cash cushion. Whether these choices pay off will depend on whether the volume momentum sustains and whether margins can stabilise as commodity inflation plays out. For now, the company has shown it can grow volumes in a tough environment. The real test is whether it can do so profitably.
